All articles by Sarah Houlton – Page 9

  • Careers

    Company Profile: James Robinson

    2010-03-31T09:03:10Z

    The UK dye manufacturer has been taken over by Vivimed, India. Sarah Houlton finds out what this means for the company

  • News

    Budget boon for science and industry

    2010-03-25T14:30:00Z

    Science and industry are offered a glimmer of hope in the latest UK budget

  • News

    Microbes implicated in Alzheimer's

    2010-03-23T13:15:00Z

    For many years, beta amyloid has been blamed for causing Alzheimer's - but could it also be protecting us from infection?

  • News

    UK must avoid 'neglected decline' in research

    2010-03-03T12:05:00Z

    Report from top science council calls for science spending to be prioritised for UK research base to remain globally competitive

  • Feature

    Painting the town green

    2010-02-26T14:23:55Z

    As new environmental legislation alters the allowed constituents of paint and varnishes, Sarah Houlton reports on how paint manufacturers are tweaking the contents of their tins

  • News

    Report hits out at GSK's Avandia

    2010-02-26T12:45:00Z

    Two US senators claim GlaxoSmithKline knew about a link between a diabetes drug and heart attack, and pressured doctors to withdraw concerns

  • News

    Europe's new research commissioner sworn in

    2010-02-17T13:00:00Z

    Máire Geoghegan-Quinn will need to make good use of her advisers to offset her lack of science background

  • News

    EU to look into chemical mixture exposure

    2010-01-12T13:39:00Z

    EU Council asks whether current legislation adequately assesses risks from exposure to multiple chemicals from different sources

  • Feature

    Operation outsource

    2010-01-06T12:37:27Z

    Western companies are now outsourcing highly skilled science work to China. Can the industry's growing demands be met, asks Sarah Houlton

  • Careers

    Who's who: Secrets of the headhunter

    2010-01-06T12:14:45Z

    Headhunters have a nose for who is right for a job but you can help yourself to be sniffed out, as Sarah Houlton finds out

  • chemotherapy-drugs-200
    News

    Pharma's year of merger mania

    2009-12-15T12:03:00Z

    Our round-up of the pharmaceutical industry in 2009 shows the fallout from this year's mega-mergers has swept across the sector

  • News

    New hep C breakthrough

    2009-12-09T13:33:00Z

    A new microRNA-based hepatitis C treatment that could avoid drug resistance is being tested on humans after encouraging trials in chimps

  • News

    A pharmaceutical named desire

    2009-11-18T14:40:00Z

    A failed antidepressant has been shown to increase women's sex drive

  • Careers

    Profile: Hair today

    2009-10-28T10:10:08Z

    Combining know-how from different businesses helped Procter & Gamble win the 2009 RSC Teamwork in innovation award for the development of hair dye product, Perfect 10

  • Careers

    Who's who: Agency access

    2009-10-28T10:09:55Z

    Recruitment agencies often offer the only route into a job, but you'll need to register with a few and be prepared to listen to what the consultants say, as Sarah Houlton reports

  • News

    ERC overhaul in wake of review

    2009-10-27T13:35:00Z

    European Research Council to streamline peer review process and hire a scientist to run the agency in response to criticism by independent review panel

  • News

    EC pushes renewables research

    2009-10-12T12:45:00Z

    European Commission calls for multi-billion euro boost for green energy research

  • News

    Chemistry of life wins Nobel

    2009-10-07T15:30:00Z

    Venkatraman Ramakrishnan, Thomas Steitz and Ada Yonath win Nobel prize for chemistry for studies of the structure and function of the ribosome

  • Careers

    The insider: Food forensics

    2009-10-01T13:56:26Z

    When food is contaminated, teams of chemists are at hand to help track down the molecular culprits, reports Sarah Houlton

  • News

    Abbott wins the race for Solvay's pharma business

    2009-09-29T12:55:00Z

    Abbott has beaten off rival bids to acquire its cholesterol-franchise partner, Solvay Pharmaceuticals.